Informed Consent to Psychedelic-Assisted Psychotherapy: Ethical Considerations
The Canadian Journal of Psychiatry January 17, 2024 Andrew G. Lee, Daniel Rosenbaum, Daniel Z. Buchman 25 citations
No Summary
Daniel Z. Buchman
3 papers in the library · 46 citations · publishing 2023-2024
Papers
Ethical Considerations at the Intersection Between Psychedelic-Assisted Psychotherapy and Medical Assistance in Dying
AJOB Neuroscience April 3, 2023 Daniel Rosenbaum, Matthew Cho, Evan Schneider et al. 11 citations
No Summary
Experiential Training in Psychedelic-Assisted Therapy: A Risk-Benefit Analysis.
Hastings Cent Rep July 1, 2024 Daniel Rosenbaum, Crystal Hare, Emma Hapke et al. 10 citations
Experiential training—where aspiring therapists undergo psychedelic-assisted therapy themselves—should not be mandatory, according to an ethical analysis applying Sandell et al.'s framework of training therapy functions. The analysis identifies five potential benefits (therapeutic, modeling, empathic, persuasive, and theoretical functions) but weighs them against six domains of risk: physical and psychological harms, negative effects on therapeutic skill, justice and equity concerns, dual relationships, privacy breaches, and undue pressure. Because many programs already include experiential components, the authors argue that the analysis can inform risk-mitigation strategies rather than justify a requirement.